humanitarian

Human medicines European public assessment report (EPAR): Constella, linaclotide, Date of authorisation: 26/11/2012, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR): Pemetrexed Baxter, pemetrexed, Date of authorisation: 09/12/2022, Status: Withdrawn

Reported by EMA What Is New Oct 1, 2026 · 15:13 UTC

Read the complete report at EMA What Is New ↗

Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT FUSION

9 reports · 2 sources

EMA What Is NewHuman medicines European public assessment report (EPAR): Constella, linaclotide, Date of authorisation: 26/11/2012, Revision: 33, Status: Authorised15:13 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Constella, linaclotide, Date of authorisation: 26/11/2012, Revision: 33, Status: Authorised15:13 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Sibnayal, potassium citrate,potassium hydrogen carbonate, Date of authorisation: 30/04/2021, Revision: 6, Status: Authori…14:46 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Sibnayal, potassium citrate,potassium hydrogen carbonate, Date of authorisation: 30/04/2021, Revision: 6, Status: Authori…14:46 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Epruvy (previously Ranibizumab Midas), ranibizumab, Date of authorisation: 19/09/2024, Revision: 5, Status: Authorised13:26 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Epruvy (previously Ranibizumab Midas), ranibizumab, Date of authorisation: 19/09/2024, Revision: 5, Status: Authorised13:26 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Byooviz, ranibizumab, Date of authorisation: 18/08/2021, Revision: 13, Status: Authorised13:01 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Byooviz, ranibizumab, Date of authorisation: 18/08/2021, Revision: 13, Status: Authorised13:01 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Pomalidomide Teva, pomalidomide, Date of authorisation: 14/11/2024, Revision: 3, Status: Authorised08:30 UTC

INCIDENT EVOLUTION

4 recorded states

Oct 1 · 15:25 UTC

Signal first indexedP2 · 99% quality · 2 sources

Oct 1 · 15:27 UTC

Headline updatedP2 · 99% quality · 2 sources

Oct 1 · 15:36 UTC

Source details updatedP2 · 99% quality · 2 sources

Oct 1 · 16:21 UTC

Source details updatedP2 · 99% quality · 2 sources

Explore this day in the archive →